Spear Pharmaceutical, Inc. – Trademark Portfolio
Entity Type: 03
Spear Pharmaceutical, Inc. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include REFISSA. The owner is based in Fort Myers, FL.
13100 Ponderosa Way
Fort Myers, FL 33907
Showing of trademarks Trademarks
Trademark Classifications
Spear Pharmaceutical, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does Spear Pharmaceutical, Inc. have?
Spear Pharmaceutical, Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 4 abandoned.
What trademark classes does Spear Pharmaceutical, Inc. file in?
Spear Pharmaceutical, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 16 (Paper Goods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Spear Pharmaceutical, Inc.'s most well-known trademarks?
Spear Pharmaceutical, Inc.'s registered trademark portfolio includes well-known marks such as REFISSA. These are among 1 currently registered trademark in the portfolio.
What is Spear Pharmaceutical, Inc.'s trademark registration success rate?
Spear Pharmaceutical, Inc. has a 20% trademark registration rate, with 1 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.